Pfizer to pay $2.3 billion, agrees to criminal plea (Reuters)
Wednesday, September 2nd, 2009Reuters – Pfizer Inc agreed on Wednesday to plead guilty to a U.S. criminal charge relating to promotion of its now-withdrawn Bextra pain medicine and will pay a record $2.3 billion to settle allegations it improperly marketed 13 medicines.